Summary
The Wellcome Trust Sanger Institute (Sanger Institute), a subsidiary of Wellcome Trust is a genomic research centre that carries out research and development in the areas of human genetics, mouse and zebrafish genetics, pathogen genetics and bioinformatics. The center’s projects include human genetics projects such as cancer genome project, genomic mutation and genetic disease, medical genomics, molecular cytogenetics and translational cancer genomics, among others. Sanger Institute works in collaboration with research, clinical and commercial partners to discover and develop information, platform technologies and early- and late-stage products. The institute focuses in the areas of immunology, cancer, public health and personalized treatment. It conducts projects on pathogen genetics, malaria, bioinformatics and cellular genetics. Sanger Institute is headquartered in Hinxton, the UK.
The Wellcome Trust Sanger Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
The Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
The Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
The Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
The Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
The Wellcome Trust Sanger Institute, Medical Devices Deals, 2010 to YTD 2016 9
The Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
The Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Sigma-Aldrich Enters into Agreement with Sanger Institute 11
AstraZeneca Enters into Research Agreement with Wellcome Trust Sanger Institute 12
Illumina Enters Into Co-Development Agreement With Wellcome Trust Sanger Institute 13
Horizon Discovery Enters Into Collaboration With Wellcome Trust Sanger Institute 14
Agilent Technologies Enters Into Co-Development Agreement With Wellcome Trust Sanger Institute and Gencode 15
Licensing Agreements 16
Oxford Gene Enters into Licensing Agreement with Wellcome Trust Sanger Institute 16
The Wellcome Trust Sanger Institute - Key Competitors 17
Key Employees 18
Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20
List of Tables
The Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Key Facts 1
The Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
The Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
The Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
The Wellcome Trust Sanger Institute, Deals By Therapy Area, 2010 to YTD 2016 8
The Wellcome Trust Sanger Institute, Medical Devices Deals, 2010 to YTD 2016 9
The Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Sigma-Aldrich Enters into Agreement with Sanger Institute 11
AstraZeneca Enters into Research Agreement with Wellcome Trust Sanger Institute 12
Illumina Enters Into Co-Development Agreement With Wellcome Trust Sanger Institute 13
Horizon Discovery Enters Into Collaboration With Wellcome Trust Sanger Institute 14
Agilent Technologies Enters Into Co-Development Agreement With Wellcome Trust Sanger Institute and Gencode 15
Oxford Gene Enters into Licensing Agreement with Wellcome Trust Sanger Institute 16
The Wellcome Trust Sanger Institute, Key Competitors 17
The Wellcome Trust Sanger Institute, Key Employees 18
List of Figures
The Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
The Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
The Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
The Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
The Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
The Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
The Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
The Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
The Wellcome Trust Sanger Institute, Medical Devices Deals, 2010 to YTD 2016 9